Old and New Drug Targets in Diabetic Retinopathy: From Biochemical Changes to Inflammation and Neurodegeneration

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|4|4|421-434

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.4, Iss.4, 2005-08, pp. : 421-434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurodegeneration in Diabetic Retina and Its Potential Drug Targets

By  

Current Neuropharmacology, Vol. 12, Iss. 4, 2014-07 ,pp. : 380-386

Bentham Science Publishers

Access to resources Recommend Favorite

MAPKs: new targets for neurodegeneration

By Harper Sarah J   Wilkie Neil  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 2, 2003-04 ,pp. : 187-200

Informa Healthcare

Access to resources Recommend Favorite

New and Old Hot Drug Targets in Tuberculosis

By  

Current Medicinal Chemistry, Vol. 23, Iss. 33, 2016-10 ,pp. : 3813-3846

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine Receptors: New Therapeutic Targets for Inflammation in Diabetic Nephropathy

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 12, Iss. 3, 2013-06 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite

Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss

By  

Current Neuropharmacology, Vol. 14, Iss. 8, 2016-11 ,pp. : 831-839

Bentham Science Publishers

Access to resources Recommend Favorite